Trend Results : Breast Cancer


Related Searches

Blog Post Results (1-20 of 10000+)

FILTER RESULTS

Novartis receives EU approval for breast cancer drug Kisqali

2 hours agoHealth : Reuters: Health

ZURICH (Reuters) - Novartis AG said its drug Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer, bolstering the Swiss drugmaker's bid to challenge U.S. rival Pfizer's Ibrance.

Auction held in Santa Ana to help Debra Tate, sister of Sharon Tate, pay for breast cancer treatment

Debra Tate is often described by those that know her as a fighter. For decades, she’s appeared at parole hearings to argue for the indefinite imprisonment of Charles Manson and his followers after the 1969 murder of her older sister, actress Sharon Tate, who was killed in the Benedict Canyon home she shared with director […]

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

Researchers found a relationship between the genetics of tumors with germline BRCA1/2 mutations and whether the tumor retains the normal copy of the BRCA1/2 gene, and risk for primary resistance to a common chemotherapy that works by destroying cancer cells' DNA.

Harvard Medical School Just Revealed an Unexpected Risk Factor For Breast Cancer

New research from Harvard Medical School just revealed an unexpected risk factor for breast cancer in young women: outdoor lights at night. In a study recently published in the journal Environmental Health Perspectives, researchers found...Show More Summary

New Recommendations for Managing Menopausal Symptoms in Breast Cancer Survivors

A large proportion of the world's estimated 9.3 million breast cancer survivors experience menopausal symptoms or clinical manifestations of estrogen deficiency. A comprehensive review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism focuses on current and future approaches to management of menopausal symptoms after breast cancer.

Study sheds light on why some breast cancers have limited response to immunotherapy

CHAPEL HILL - UNC Lineberger Comprehensive Cancer Center researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

(University of Pennsylvania School of Medicine) Researchers found a relationship between the genetics of tumors with germline BRCA1/2 mutations and whether the tumor retains the normal copy of the BRCA1/2 gene, and risk for primary resistance to a common chemotherapy that works by destroying cancer cells' DNA.

Retention of One Normal Version of BRCA Gene in Breast and Ovarian Cancers Influences Patient Survival, According to Penn-Led Study

Researchers found a relationship between the genetics of tumors with germline BRCA1/2 mutations and whether the tumor retains the normal copy of the BRCA1/2 gene, and risk for primary resistance to a common chemotherapy that works by destroying cancer cells' DNA.

Dying At Home In An Opioid Crisis: Hospices Grapple With Stolen Meds

yesterdayHealth : The Checkup

Nothing seemed to help the patient — and hospice staff didn’t know why. They sent home more painkillers for weeks. But the elderly woman, who had severe dementia and incurable breast cancer, kept call...

Immune cells contribute to treatment resistance in aggressive breast cancers

(JCI Journals) Although early detection and targeted therapies have improved patient survival, breast cancer remains a leading cause of cancer-related death for women in the United States. This week in the JCI, researchers in Jon Serody's...Show More Summary

Study sheds light on why some breast cancers have limited response to immunotherapy

(UNC Lineberger Comprehensive Cancer Center) In the Journal of Clinical Investigation, UNC Lineberger Comprehensive Cancer Center researchers report on their study that explored a perplexing question: Why were drugs designed to unleash...Show More Summary

Searching for the 'signature' causes of BRCAness in breast cancer

(Broad Institute of MIT and Harvard) Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature known in cancer genomics as 'Signature 3.' But not all breast tumor cells exhibiting Signature 3 have BRCA1 or BRCA2 mutations. Show More Summary

Study suggests possible link between urban lighting and breast cancer

New research reveals an unexpected potential risk factor for breast cancer: city lights. The Harvard Medical School study found an association between living in areas with high amounts of ambient nighttime light and slightly increased odds for breast cancer in younger women who smoke. "In our modern...

U.S. study revives argument over mammogram screening

(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.

Comparison of screening recommendations indicates annual mammography

(Wiley) When to initiate screening for breast cancer, how often to screen, and how long to screen are questions that continue to spark emotional debates.

Olivia Newton-John ‘feeling great’ after breast cancer relapse

3 days agoNews : NY Daily News

Months after facing a relapse in her fight against breast cancer, Olivia Newton-John is preparing a return to the stage.

Hyperthyroidism update: Breast cancer, hypothyroidism vs hyperthyroidism, atrial fibrillation, atherosclerosis

The thyroid is a gland found in the neck that is responsible for secreting thyroid hormone, which primarily influences metabolic rate and protein synthesis. An estimated 20 million Americans have some sort of thyroid disease, with 60...Show More Summary

Harvard study strengthens link between breast cancer risk and light exposure at night

4 days agoNews : The Raw Story

By Richard G. “Bugs” Stevens, Professor, School of Medicine, University of Connecticut. Artificial light has transformed the night sky, a change researchers continue to link to health problems. Fabio Falchi et al, CC BY-ND A new study from Harvard has found greater risk of breast...

Few Women with History of Breast Cancer and Ovarian Cancer Take a Recommended Genetic Test

More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.

Olivia Newton-John Returns With A Heartwarming Message To Her Fans Following Breast Cancer Relapse — Watch!

We're glad she's doing well! As we reported, in May, Olivia Newton-John announced she was postponing her tour after she received a second breast cancer diagnosis. The Grease actress was first hit with the illness in 1992 where she underwent...Show More Summary

Copyright © 2015 Regator, LLC